If You Buy Fluor (FLR) Stock Today, Here's the Bull Case for the Next 5 Years

Fluor’s backlog reached $25.5 billion at the end of 2025, with more than 80% in reimbursable contracts, while analysts expect a return to profitability in 2026 and EPS growth of 16% CAGR through 2028. The company still faces execution issues, cost overruns, and a one-time legal payment to Santos, but its NuScale stake and planned share buybacks could support future EPS. The article’s core message is constructive on Fluor’s five-year outlook, though the near-term setup remains mixed.

Analysis

The market is likely underappreciating how much of FLR’s rerating comes from de-risking the earnings base rather than just cyclical growth. Moving toward reimbursable work lowers headline margin, but it also compresses the dispersion of outcomes, which should support a higher forward multiple as the company transitions from a “project roulette” story to a steadier industrial cash-flow compounder. That matters because buybacks funded by asset monetization become far more powerful when the core business is less volatile; every incremental repurchase has a cleaner effect on EPS than it did in the fixed-price era.

The bigger second-order winner may be SMR rather than FLR. The NuScale stake is effectively a call option on the power bottleneck behind AI infrastructure, and that exposure can re-rate FLR even if construction execution is only average; however, it also makes reported earnings noisier and can distort investor perception of operating quality. If SMR weakens, the market may suddenly value FLR more on fundamentals and less on “venture-like” mark-to-market upside, which could actually be a positive for a long-only industrial shareholder base.

The main risk is timing: the backlog is supportive, but the earnings inflection depends on project starts, client funding, and litigation/cost leakage staying contained over the next 2-6 quarters. Any renewed execution miss would be punished disproportionately because the stock has already priced in a cleaner conversion from backlog to cash flow. Consensus may be too linear on the 2026-2028 EPS ramp; in a messy macro, the path will likely be lumpy, and the stock can de-rate quickly if investors conclude the AI/infrastructure supercycle is getting pushed out rather than merely delayed.

Key Decisions for Investors

• Long FLR on pullbacks over the next 1-3 months; target a 12-18 month hold into the 2026 profitability inflection. Risk/reward is attractive if the market keeps paying up for lower-variance industrial cash flow, but trim on any new project miss.
• Pair trade: long FLR / short an execution-sensitive EPC peer with heavier fixed-price exposure. The cleaner backlog mix should command a relative premium if the market remains focused on earnings quality over raw growth.
• Treat SMR as a separate event-driven call option rather than a core thesis input for FLR. For investors already long FLR, consider using SMR strength to fade the embedded optionality and lock in gains if the stake continues to drive the stock more than operations.
• Use call spreads on FLR for a 6-12 month horizon instead of outright equity if you want upside to the EPS re-rating while capping risk from another litigation or execution surprise.